ACZONE

This brand name is authorized in Canada, New Zealand, United States

Active ingredients

The drug ACZONE contains one active pharmaceutical ingredient (API):

1 Dapsone UNII 8W5C518302 - DAPSONE

Dapsone is a sulfone active against a wide range of bacteria. Dapsones mechanism of action is probably similar to that of the sulfonamides which involves inhibition of folic acid synthesis in susceptible organisms. Read about Dapsone

Medication package inserts

Below package inserts are available for further reading:

Title	Information Source	Document Type
ACZONE Gel	FDA, National Drug Code (US)	MPI, US: SPL/PLR

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
D10AX05		D Dermatologicals → D10 Anti-acne preparations → D10A Anti-acne preparations for topical use → D10AX Other anti-acne preparations for topical use
Discover more medicines within D10AX05

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 18304
Country: US	FDA, National Drug Code	Identifier(s): 0023-3670, 0023-5206, 16110-526